Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Hemophilia A
Recent news which mentions Hemophilia A
Sanofi-SOBI Hemophilia Candidate Aces Late-Stage Study In Pretreated Patients
March 09, 2022
Tickers
BIOVF
SNY
Tags
Market News
News
SNY
From
Benzinga
BioMarin's Hemophilia Gene Therapy Meets Efficacy Endpoints At Two Year Analysis
January 10, 2022
Tickers
BMRN
Tags
Market News
General
Hemophilia A
From
Benzinga
Sanofi Reveals Late-Stage Data For Fitusiran In Hemophilia Patients
December 14, 2021
Tickers
SNY
Tags
Market News
ASH21
Hemophilia A
From
Benzinga
Generation Bio Hits 52-Week Low After Preclinical Data From Hemophilia A Program
December 14, 2021
Tickers
GBIO
Tags
Preclinical Phase
Market News
why it's moving
From
Benzinga
Sigilon Therapeutics Issues An Update On Its Early-Stage Hemophilia Study
November 29, 2021
Tickers
SGTX
Tags
General
SGTX
Phase 2 Trial
From
Benzinga
Centessa Stock Surges On Positive Data From Hemophilia Candidate
September 09, 2021
Tickers
CNTA
Tags
why it's moving
Market News
hemophilia B
From
Benzinga
BioMarin Shares 5-Year Data From Open-Label Trial Of Hemophilia Gene Therapy
July 21, 2021
Tickers
BMRN
Tags
Phase 2 Trial
General
Biotech
From
Benzinga
Spark Therapeutics' Hemophilia Gene Therapy Achieve Stable, Durable FVIII Expression
July 21, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBF
RHHVF
General
From
Benzinga
Roche Unveils New Hemlibra Data Reinforcing Safety Profile In Hemophilia A
July 19, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Hemophilia A
Health Care
News
From
Benzinga
BioMarin Expects EMA's CHMP Opinion In 1H 2022 For Its Hemophilia A Gene Therapy, FDA Resubmission In 2Q'22
July 15, 2021
Tickers
BMRN
Tags
FDA
General
Market News
From
Benzinga
Serious Adverse Event Triggers FDA Clinical Hold On Sigilon Therapeutics' Hemophilia A Trial, Shares Drop
July 09, 2021
Tickers
SGTX
Tags
Market News
General
SGTX
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.